Novartis former CEO joins Anthropic BoD (www.anthropic.com)

Vas Narasimhan, former CEO of Novartis, has joined Anthropic's Board of Directors, appointed by the Anthropic Long-Term Benefit Trust. Narasimhan, a physician-scientist with extensive experience in the pharmaceutical industry, aligns with Anthropic's belief in AI's transformative potential in healthcare and life sciences. His background includes overseeing the development of over 35 novel medications, emphasizing his capability to guide technological innovations in highly regulated environments. This appointment is significant for the AI/ML community as it enhances Anthropic’s governance with a focus on balancing financial success with its mission to develop AI that benefits humanity. With Narasimhan's expertise in responsible science stewardship, Anthropic aims to set new standards in AI development, particularly in addressing complex challenges in healthcare. His perspectives on technology’s role in advancing medicine and global health will likely shape the company’s strategic direction, potentially resulting in more responsible AI applications that improve quality of life across diverse populations.